Design and Synthesis of a Series of Pyrido[2,3-d]pyrimidine Derivatives as CCR4 Antagonists

A series of pyrido[2,3-d]pyrimidine derivatives were designed and synthesized based on known CC chemokine receptor 4 (CCR4) antagonists. The activities of all the newly synthesized compounds were evaluated using a chemotaxis inhibition assay. Compound 6b was proven to be a potent CCR4 antagonist that can block cell chemotaxis induced by macrophage-derived chemokine (MDC), thymus and activation regulated chemokine (TARC), and CKLF1, the natural ligands of CCR4. In addition, compound 6b is more effective than budesonide in the murine rhinitis model. The intravenous injection LD50 of compound 6b is 175 mg/kg and the oral LD50 is greater than 2,000 mg/kg.

[1]  Enquan Xu,et al.  An Antagonist for CCR4 Alleviates Murine Allergic Rhinitis by Intranasal Administration , 2012, International Archives of Allergy and Immunology.

[2]  P. Howarth,et al.  Chemokine Receptor 4 Plays a Key Role in T Cell Recruitment into the Airways of Asthmatic Patients , 2010, The Journal of Immunology.

[3]  Dongmei Wang,et al.  Discovery and optimization of novel 3-piperazinylcoumarin antagonist of chemokine-like factor 1 with oral antiasthma activity in mice. , 2010, Journal of medicinal chemistry.

[4]  H. Hammad,et al.  Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC‐derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation , 2009, Allergy.

[5]  P. Bauer,et al.  Bipiperidinyl Carboxylic Acid Amides as Potent, Selective, and Functionally Active CCR4 Antagonists , 2007, Chemical biology & drug design.

[6]  B. Jaffee,et al.  Small molecule antagonists of the CC chemokine receptor 4 (CCR4). , 2007, Bioorganic & medicinal chemistry letters.

[7]  K. McIntyre,et al.  Core exploration in optimization of chemokine receptor CCR4 antagonists. , 2007, Bioorganic & medicinal chemistry letters.

[8]  A. Purandare,et al.  Antagonists of CCR4 as immunomodulatory agents. , 2006, Current topics in medicinal chemistry.

[9]  T. Schall,et al.  Optimization of 2-aminothiazole derivatives as CCR4 antagonists. , 2006, Bioorganic & medicinal chemistry letters.

[10]  J. Wityak,et al.  Identification of chemokine receptor CCR4 antagonist. , 2005, Bioorganic & medicinal chemistry letters.

[11]  J. García-Foncillas,et al.  Synthesis and biological evaluation of new symmetrical derivatives as cytotoxic agents and apoptosis inducers. , 2005, Bioorganic & medicinal chemistry.

[12]  Aaron S. Anderson,et al.  Racemic and chiral lactams as potent, selective and functionally active CCR4 antagonists. , 2004, Bioorganic & medicinal chemistry letters.

[13]  G. Zeng,et al.  Chemokine-like factor 1, a novel cytokine, contributes to airway damage, remodeling and pulmonary fibrosis. , 2004, Chinese medical journal.

[14]  L. Wang,et al.  Molecular cloning and characterization of chemokine-like factor 1 (CKLF1), a novel human cytokine with unique structure and potential chemotactic activity. , 2001, The Biochemical journal.

[15]  I. Homma,et al.  Intervention of Thymus and Activation-Regulated Chemokine Attenuates the Development of Allergic Airway Inflammation and Hyperresponsiveness in Mice1 , 2001, The Journal of Immunology.

[16]  G. Yu,et al.  Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. , 1999, Journal of immunology.

[17]  P. Allavena,et al.  Human Macrophage–derived Chemokine (MDC), a Novel Chemoattractant for Monocytes, Monocyte-derived Dendritic Cells, and Natural Killer Cells , 1997, The Journal of experimental medicine.

[18]  O. Yoshie,et al.  Molecular Cloning of a Novel T Cell-directed CC Chemokine Expressed in Thymus by Signal Sequence Trap Using Epstein-Barr Virus Vector* , 1996, The Journal of Biological Chemistry.

[19]  S. Chensue,et al.  CC chemokine receptor 4 contributes to innate NK and chronic stage T helper cell recall responses during Mycobacterium bovis infection. , 2011, The American journal of pathology.

[20]  M. Takeuchi,et al.  Potent and orally bioavailable CCR4 antagonists: Synthesis and structure-activity relationship study of 2-aminoquinazolines. , 2009, Bioorganic & medicinal chemistry.

[21]  Dan Li,et al.  Two C-terminal peptides of human CKLF1 interact with the chemokine receptor CCR4. , 2008, The international journal of biochemistry & cell biology.

[22]  K. McIntyre,et al.  Optimization of CCR4 antagonists: side-chain exploration. , 2006, Bioorganic & medicinal chemistry letters.